Brian R. Skene
ACD/CD/Senior Copy Creative
Therapeutic Expertise
Oncology, gene therapy, rare disease, respiratory, CNS (MS, MDD, schizophrenia, pseudobulbar affect), cardiology, dermatology, diabetes, hematology, HIV, stroke, hemophilia, surgical devices, acid reflux disease, infertility
Pitchwork
Led copy development for 2 successful new business pitches:
- VYJUVEK / Krystal Biotech (dystrophic epidermolysis bullosa)
- ARCUS BioSciences (cancer immunotherapy)
Selected Work
VYJUVEK / Krystal Biotech
Gene therapy, dystrophic epidermolysis bullosa
Led prelaunch creative for the first FDA-approved redosable topical gene therapy
XARELTO / Janssen Pharmaceuticals
Anticoagulation, multiple indications
Oversaw strategic copy for 7th and 8th indications; institutional, LTC, and HCP rollouts
AMONDYS 45 / Sarepta Therapeutics
RNA-based therapy for Duchenne muscular dystrophy
Built launch platform; managed relaunch of Duchenne.com (HCP + patient)
UTIBRON / SEEBRI / ARCAPTA / Sunovion
Respiratory triple launch
Drove creative across brands and markets; supported post-launch growth into consumer and LTC
BREO + ARNUITY / GlaxoSmithKline
Asthma + COPD
Breo launch called “most flawless in GSK history”
OCREVUS / Genentech
Multiple sclerosis
Created unbranded platform + global messaging in anticipation of launch
Experience
ACD (Freelance)
Eversana Intouch, Avalere Health, Broth Agency
2023—Present
- Created pre-launch tactics for CASGEVY, first FDA-approved CRISPR/Cas9 therapy for sickle-cell disease and β-thalassemia
- Supported launches for LYMPHIR (r/r CTCL), NEMLUVIO (atopic dermatitis/prurigo nodularis), EPKINLY (diffuse large B-cell lymphoma), and LIVDELZI (primary biliary cholangitis)
- Helped create HCP and patient tactics for TYVASO (interstitial lung disease) and RADICAVA (amyotrophic lateral sclerosis)
ACD (Fulltime)
McCann Health New York/IPG
2021—2023
- Pitch wins: ARCUS BIOSCIENCES (cancer immunotherapy); KRYSTAL BIOTECH (dystrophic epidermolysis bullosa)
- Copy Lead on SAREPTA THERAPEUTICS' RNA-based Duchenne Muscular Dystrophy franchise
- Relaunched LEVULAN KERASTICK + BLU-U & ODOMZO for SUN PHARMA
- Mentored junior writers, co-taught agency workshop on creative briefs
ACD (Freelance)
RealityRx/Various
2018—2020
- Led copy development for 7 INTEGRA LIFESCIENCES relaunches (surgical devices)
VP ACD
Concentric Health Experience
2017—2018
- Directed creative across 4 workstreams; managed 8 writers for launch of SUNOVION respiratory franchise
- Messaging lead on REXULTI (MDD and Schizophrenia) for OTSUKA/LUNDBECK
Group Copy Supervisor
Ogilvy CommonHealth
2015—2016
- Developed global and US tactics for OCREVUS (multiple sclerosis) and BYDUREON (type II diabetes)
Also
- Wrote/directed/produced 50+ nationally distributed health and culture programs for PBS and Lifetime Medical Television
- Nominated for 4 Emmy Awards, including Best Health Program and Best Research